Gene · 406987
Papers4,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-204 Negatively Regulates HIV-Tat-Mediated Inflammation in Cervical Epithelial Cells via the NF-κB Axis: Insights from an In Vitro Study. | Cells | 2026 | 41597192 | PubTator, text mining | PubMed |
| Correlation of miR-214, miR-204, miR-25, miR-15a Expression with IL-33 and Malondialdehyde in Blood Samples from Patients with Alzheimer's Disease. | Microrna | 2026 | 41589493 | PubTator, text mining | PubMed |
| Integrative multi-omics and machine learning framework identifies PRDX4 as a redox-EMT regulator and predictive marker in bone-metastatic breast cancer. | NPJ Precis Oncol | 2026 | 41571856 | PubTator, text mining | PubMed |
| Upregulated miR-204-5p inhibits oral squamous cell carcinoma progression via inducing autophagy-promoted apoptosis by targeting PIK3CB. | Sci Rep | 2026 | 41571749 | PubTator, text mining | PubMed |
| Diagnostic value and role in promoting fracture healing of deregulated circulating miR-204 in patients with osteoporotic fractures. | J Orthop Surg Res | 2026 | 41535940 | PubTator, text mining | PubMed |
| Exploring extracellular vesicle MicroRNAs in Usher syndrome type 1B: Tear-Derived EVs as potential indicators of retinal health. | Cell Mol Life Sci | 2026 | 41528484 | PubTator, text mining | PubMed |
| Retraction Notice to: Oncogenic Role of Long Noncoding RNAMALAT1 in Thyroid Cancer Progression through Regulation of the miR-204/IGF2BP2/m6A-MYC Signaling. | Mol Ther Nucleic Acids | 2026 | 41509606 | PubTator, text mining | PubMed |
| PHOX2B deletion in congenital central hypoventilation syndrome: is this sufficient for pathogenesis? | J Hum Genet | 2026 | 41188450 | PubTator, text mining | PubMed |
| Tear fluid participates in systemic immunity. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | 41656821 | PubTator, text mining | PubMed |
| Analysis of the expression of ARNTL2 and miR-204-5p and their correlation with clinical pathological features in NSCLC patients. | Am J Clin Exp Immunol | 2025 | 41567727 | PubTator, text mining | PubMed |
| Extracellular vesicle-associated lncRNA LYPLAL1-DT mediates endothelial-cancer cell communication, promoting small cell lung cancer progression. | Extracell Vesicles Circ Nucl Acids | 2025 | 41551597 | PubTator, text mining | PubMed |
| Aging and lung diseases: Unraveling mechanisms and therapeutic targets. | Chin Med J Pulm Crit Care Med | 2025 | 41551014 | PubTator, text mining | PubMed |
| LINC01980 promotes the malignant progression of lung squamous carcinoma by targeting miR-204-3p. | Hereditas | 2025 | 41390751 | PubTator, text mining | PubMed |
| Indoxyl sulfate promoted glutamine metabolism and cell proliferation in urothelial carcinoma involving Runx2. | Biomed Pharmacother | 2025 | 41337885 | PubTator, text mining | PubMed |
| Extracellular vesicles from long COVID patients promote RUNX2-mediated cellular stress via dysregulated miR-204 and p53 pathway activation. | Cell Commun Signal | 2025 | 41299665 | PubTator, text mining | PubMed |
| Exploring the potential of stem cells from the apical papilla (SCAPs) in regenerative medicine: advantages, applications, challenges and opportunities. | Stem Cell Res Ther | 2025 | 41204348 | PubTator, text mining | PubMed |
| Exosomes in HPV-Associated Cancers: From Biomarkers to Engineered Therapeutics. | Cancers (Basel) | 2025 | 41154440 | PubTator, text mining | PubMed |
| Scientometric analysis of extracellular vesicles in vision science (up to 2024). | J Nanobiotechnology | 2025 | 41074034 | PubTator, text mining | PubMed |
| Key genes associated with brain metastasis in non-small cell lung cancer: novel insights from bioinformatics analysis. | Front Bioinform | 2025 | 41048344 | PubTator, text mining | PubMed |
| LncRNA LINC00704 drives cancer stemness and malignant properties in oral squamous cell carcinomas by sponging miR-204. | J Dent Sci | 2025 | 41040556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406987/papers?page=4